Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr David Jamieson

Newcastle AuthorsTitleYearFull text
Dr Pawan Gulati
Dr Vickyanne Carruthers
Dr Claire Hutton
Chloe Cassidy
Dr Edward Amankwatia
et al.		An assessment of circulating biomarkers and germline genetic variants in predicting chemotherapy associated mucositis in Ewing sarcoma2025
Dr Marina Danilenko
Sharanya Nath
Jack Baines
Freya Gordon
Swathi Merugu
et al.		Detection of Targetable Genetic Abnormalities in Neuroblastoma Circulating Tumour DNA2025
Dr Shelby Barnett
Dr Martin Galler
Dr David Jamieson
Professor Gareth Veal
Excessive vincristine exposure in a child being treated for acute lymphoblastic leukaemia with underlying Dubin–Johnson syndrome: a case report2023
Dr Oladipo Idowu
Professor Gareth Veal
Dr David Jamieson
Development and validation of an ELISA method for quantification of the anti-HER3 antibody HMBD-001 in human serum2022
Dr Shelby Barnett
Julie Errington
Julieann Sludden
Dr David Jamieson
Professor Gareth Veal
Pharmacokinetics and pharmacogenetics of cyclophosphamide in a neonate and infant childhood cancer patient population2021
Swathi Merugu
Dr Lindi Chen
Elizabeth Gavens
Hany Gabra
Dr Al Gabriel
et al.		Detection of circulating and disseminated neuroblastoma cells using the Imagestream Imaging Flow Cytometer for use as predictive and pharmacodynamic biomarkers2020
Marian Case
Dr Dino Masic
Dr David Jamieson
Dr Frederik van Delft
Professor Andrew Filby
et al.		Label-Free Leukemia Monitoring by Computer Vision2020
Suriyon Uitrakul
Dr Claire Hutton
Professor Gareth Veal
Dr David Jamieson
A novel imaging flow cytometry method for the detection of histone H4 acetylation in myeloid cells2019
Dr Sarah Fordham
Dr Helen Blair
Dr Claire Elstob
Professor Ruth Plummer
Dr Yvette Drew
et al.		Inhibition of ATR acutely sensitises acute myeloid leukemia cells to nucleoside analogs that target ribonucleotide reductase2018
Dr Jane Margetts
Laura Ogle
Dr Anthony Chan
Dr David Jamieson
Dr Catherine Willoughby
et al.		Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?2018
Professor Gareth Veal
Dr David Jamieson
Katja Kuver
Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial2017
Dr David Jamieson
Dr Nicola Sunter
Sara Muro
Dr Nicola Cresti
Julieann Sludden
et al.		Pharmacogenetic association of MBL2 and CD95 polymorphisms with grade 3 infection following adjuvant therapy for breast cancer with doxorubicin and cyclophosphamide2017
Professor Edvaldo Ribeiro Rosa
Dr Deepali Pal
Dr David Jamieson
Dr Kenneth Rankin
Dr Matthew Benning
et al.		Temporary Single Cell Coating for Bioprocessing via a Cationic Polymer2017
Dr David Jamieson
Melanie Griffin
Julieann Sludden
Dr Yvette Drew
Dr Nicola Cresti
et al.		A phase I pharmacokinetic and pharmacodynamic study of the oral mitogen-activated protein kinase kinase (MEK) inhibitor, WX-554, in patients with advanced solid tumours2016
Dr Nicola Wyatt
Dr Linda Hogarth
Dianne Turner
Dr Miranda Morton
Dr David Jamieson
et al.		Circulating Biomarkers of Frailty Are Associated with a Poor Prognosis in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)2016
123